Interpore Cross International

The Irvine manufacturer of spinal implant devices and synthetic bone and tissue products said net income for the third quarter totaled $1.2 million, or 8 cents a share, slightly lower than the $1.4 million, or 10 cents a share, a year ago. Sales grew 12% to $10.6 million.

* Core Inc. said shareholders have approved the Irvine company's acquisition by Fortis Inc., a New York financial services group, for $4.92 a share, or about $45 million. The transaction could be wrapped up this week, said Core, which manages disability and other employee absence benefits. Core's stock closed at $4.89, down 1 cent a share, on Nasdaq.

Interpore Cross International said Tuesday its new bone plate system for treating internal pelvic fractures has been cleared by the Food and Drug Administration. The Irvine medical device company expects the system to be ready for market launch as early as first quarter 1999. Interpore's stock was unchanged Tuesday at $4.63.

Interpore Cross International has agreed to acquire American OsteoMedix, a Virginia maker of minimally invasive medical devices, for more than $20 million in cash and stock, the Irvine company announced Thursday. Interpore, a medical-device company, said it will pay about $8 million in cash and roughly 2.4 million shares, subject to adjustment. The shares are worth about $12.6 million, based on Interpore's Thursday closing price of $5.23.

Interpore Cross International: The Irvine medical device manufacturer said net income for the first quarter rose 15% to $1.1 million, or 8 cents a share, from $943,000, or 7 cents a share, for the first quarter of 1998. Sales grew 22% to a record $9 million from $7.4 million.

Irvine-based Interpore International completed its acquisition of Cross Medical Products Inc. of Dublin, Ohio, and is changing its name to Interpore Cross International. Cross Medical was acquired in a stock swap. Interpore, which makes synthetic bone and tissue products, will remain headquartered in Irvine.

Interpore Cross International, Irvine designer and manufacturer of spinal implant devices and synthetic bone and tissue products, said net income for the first quarter totaled $1.2 million, or 8 cents a share, up 9% from $1.1 million, or 8 cents a share, a year ago. Sales rose 27% to a record $11.4 million.

Irvine medical device firm Interpore Cross International reported second-quarter net income of $974,000, or 7 cents a share, which included a one-time charge of $268,000 from the withdrawal of its proposed secondary public stock offering. That compared with net income of $1.1 million, or 8 cents a share, for last year's second quarter. Sales grew 18% to $11.3 million.

Interpore Cross International said it paid $500,000 and issued 100,000 shares of unregistered common stock to acquire the intellectual property of Quantic Biomedical Inc. in San Rafael, Calif. Interpore, an Irvine maker of spinal implants and synthetic bone and tissue products, said it also issued warrants to purchase stock at prices above the current market price and will continue to pay unspecified royalties on sales to the former owners.

Irvine medical device firm Interpore Cross International posted fourth-quarter net income of $824,000, or 6 cents a share, down 33% from $1.2 million, or 9 cents a share, a year ago. Sales grew 2% to $10.9 million. Net income for 2000 was $4.1 million, or 27 cents a share, a decrease of 15% from $4.8 million, or 35 cents a share, for 1999. Sales increased 14% to a record $44.3 million.

Interpore Cross International Inc. said Wednesday it filed a patent infringement lawsuit against Johnson & Johnson unit. Neither Johnson & Johnson nor its unit, Depuy AcroMed could immediately be reached for comment. Interpore, an Irvine medical device firm, said it believes that some of Depuy AcroMed's products infringe on Interpore's variable-locking-screw technology used in a spinal implant system. The lawsuit, filed in the U.S. District Court, seeks unspecified damages.

The Irvine manufacturer of spinal implant devices and synthetic bone and tissue products said net income for the third quarter totaled $1.2 million, or 8 cents a share, slightly lower than the $1.4 million, or 10 cents a share, a year ago. Sales grew 12% to $10.6 million.

Irvine medical device firm Interpore Cross International reported second-quarter net income of $974,000, or 7 cents a share, which included a one-time charge of $268,000 from the withdrawal of its proposed secondary public stock offering. That compared with net income of $1.1 million, or 8 cents a share, for last year's second quarter. Sales grew 18% to $11.3 million.

A Huntington Beach provider of high-speed Internet access said it wants to go public at a time when an unsteady stock market has prompted another Orange County biotech company to abandon its planned stock offering. Despite the volatile market, Flashcom Inc. said it hopes to raise as much as $125 million, according to a document it filed with the Securities and Exchange Commission. No price per share or date for the initial public offering has been set.

Interpore Cross International, which makes synthetic bone and tissue products and spinal implant devices, said revenue set records for the fourth quarter and year. The Irvine company said revenue grew 22% to $8.2 million from $6.7 million a year ago. Net sales for the year climbed 6.3% to $30.2 million from $28.4 million the previous year, which included $1.7 million of sales from the divested dental business. The company noted that the results are preliminary.

Interpore Cross International, Irvine designer and manufacturer of spinal implant devices and synthetic bone and tissue products, said net income for the first quarter totaled $1.2 million, or 8 cents a share, up 9% from $1.1 million, or 8 cents a share, a year ago. Sales rose 27% to a record $11.4 million.

Interpore Cross International, an Irvine maker of spinal implant devices and synthetic bone and tissue products, said net income for the fourth quarter increased 57% to $1.2 million, or 9 cents a share, from $788,000, or 5 cents a share, for the fourth quarter of 1998. Net income for the 1999 period included a $407,000 reduction for income taxes. Sales grew 30% to a record $10.7 million. Net income for the year totaled $4.8 million, or 35 cents a share, compared with a net loss of $2.